Related Experiment Video
Updated: Aug 13, 2026

A New Method for Inducing a Depression-Like Behavior in Rats
Published on: February 22, 2018
Considerations in the management of the patient with comorbid depression and anxiety
L Kathleen Sekula1, Joe DeSantis, Vincent Gianetti
1School of Nursing, Duquesne University, Pittsburgh, PA, USA. sekula@duq.edu
Purpose:
To provide clinicians with guidelines for the assessment, evaluation, diagnosis, and management of comorbid depression and anxiety in the primary care setting.
Data Sources:
Research-based articles in the medical and psychiatric literature, literature reviews by experts in the field, and DSM-IV-TR.
Conclusions:
Comorbid anxiety and depression occurs at a high rate in primary care, and is costly to both the individual and to society. These patients most often present in primary care settings, have more severe symptoms, and require more health care resources. The presentation of depression and anxiety together pose complicated diagnostic and treatment challenges, leading to inadequate diagnosis and treatment resulting in unnecessary patient distress and increased utilization of health care services.
Implications For Practice:
This article is a review of comorbid depression and anxiety with a focus upon societal and patient significance and impact, under recognition and under treatment, diagnostic challenges, medical comorbidity, treatment considerations, and educational strategies. Effective assessment, evaluation, diagnosis and treatment can lead to better treatment outcomes and improved quality of life in primary care patients.
Related Concept Videos
Antidepressant Drugs: Overview
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Acute Coronary Syndrome IV: Interprofessional Care
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
